Cite
HARVARD Citation
Milton, C. et al. (2022). FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas. Molecular oncology. 16 (6), pp. 1272-1289. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Milton, C. et al. (2022). FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas. Molecular oncology. 16 (6), pp. 1272-1289. [Online].